Multiple sclerosis is highly prevalent in Alberta and is characterized by loss of myelin (brain white matter) and myelin-producing cells, oligodendrocytes. This leads to neurodegeneration and symptoms like blurred vision, impaired cognition, loss of mobility and/or paralysis. Currently there are no treatments aimed to replace lost oligodendrocytes and myelin. This can be achieved by stimulating […]
Read More